Samuel DeLeon
Impact in
- Physiology top 10%
- Asthma and respiratory diseases
- Otorhinolaryngology top 10%
- Sinusitis and nasal conditions
Papers in
-
- Asthma and respiratory diseases 7
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 3
- Co-authors
- Elisa S. Weiss (1 shared paper)Arthur E. Blank (1 shared paper)Bruce David Rapkin (1 shared paper)Paul Meißner (1 shared paper)
- Journals
- The Journal of Allergy and Clinical Immunology In Practice (3 papers)The Lancet Respiratory Medicine (3 papers)Respiratory Medicine (2 papers)Diabetes Care (1 paper)Respiratory Research (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Samuel DeLeon
13 papers receiving 435 citations
Samuel DeLeon's Hit Papers
Peers
Comparison fields: 5 of 41
- Physiology 278
- Otorhinolaryngology 34
- Pulmonary and Respiratory Medicine 60
- Infectious Diseases 30
- Endocrinology, Diabetes and Metabolism 21
Countries citing papers authored by Samuel DeLeon
This map shows the geographic impact of Samuel DeLeon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel DeLeon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel DeLeon more than expected).
Fields of papers citing papers by Samuel DeLeon
This network shows the impact of papers produced by Samuel DeLeon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel DeLeon. The network helps show where Samuel DeLeon may publish in the future.
Co-authors
The 4 scholars most cited alongside Samuel DeLeon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 150 | |
| 2 | Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study Hit paper breakdown → | 2023 | 117 |
| 3 | 2022 | 36 | |
| 4 | 2021 | 31 | |
| 5 | 2020 | 30 | |
| 6 | 2023 | 22 | |
| 7 | 2023 | 20 | |
| 8 | 2022 | 17 | |
| 9 | 2021 | 13 | |
| 10 | 2023 | 6 | |
| 11 | 2023 | 4 | |
| 12 | 2019 | 1 | |
| 13 | 2026 | 1 |
About Samuel DeLeon
Samuel DeLeon is a scholar working on Physiology, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Infectious Diseases, having authored 13 papers that have together received 448 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (7 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers), Heart Failure Treatment and Management (2 papers), Diabetes Treatment and Management (1 paper), Community Health and Development (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Physiology (278 citations), Otorhinolaryngology (34 citations), Pulmonary and Respiratory Medicine (60 citations), Infectious Diseases (30 citations) and Endocrinology, Diabetes and Metabolism (21 citations). Samuel DeLeon has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Elisa S. Weiss, Arthur E. Blank, Bruce David Rapkin and Paul Meißner. Their work appears in journals such as The Journal of Allergy and Clinical Immunology In Practice, The Lancet Respiratory Medicine, Respiratory Medicine, Diabetes Care and Respiratory Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.